Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 721 AL 735

Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management

Wei X, Li L, Zhao G, Luan Y, Wang Q, Ning W.

Clin Exp Hypertens. 2025 Dec 31;47(1):2595154. doi: 10.1080/10641963.2025.2595154. Epub 2025 Dec 5.

Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective

Scarano N, Musumeci F, Casini B, Brullo C, D'Ursi P, Fossa P, Schenone S, Cichero E.

Int J Mol Sci. 2025 Jul 20;26(14):6980. doi: 10.3390/ijms26146980.

Brexpiprazole: A Balance of Risks and Benefits

Hitt EM.

Sr Care Pharm. 2025 Mar 1;40(3):115-122. doi: 10.4140/TCP.n.2025.115.

Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative Review

Serio MA, Dethloff DR, Curry GC, Beesley ML, Shekoohi S, Kaye AD.

Adv Ther. 2025 Nov;42(11):5300-5312. doi: 10.1007/s12325-025-03337-x. Epub 2025 Aug 29.

Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease

Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.

CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.

Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review

Diamandis N, van den Anker JN, Denisova K.

Transl Psychiatry. 2025 Nov 17;15(1):475. doi: 10.1038/s41398-025-03655-2.

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS.

Alzheimers Dement. 2025 Jun;21(6):e70258. doi: 10.1002/alz.70258.

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies

Smoller C, Schiller E, Yamashita K, Silverglate BD, Grossberg GT.

Drugs. 2025 Nov;85(11):1391-1411. doi: 10.1007/s40265-025-02227-4. Epub 2025 Sep 6.

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease

Zhong K, Cummings J.

Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.

Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment

Lee HH, Chinnameyyappan A, Feldman OJ, Marotta G, Survilla K, Lanctôt KL.

Curr Top Behav Neurosci. 2025;69:245-273. doi: 10.1007/7854_2024_566.

A US-based practitioner's guide to diagnosis, evaluation, and evidence-based treatment of agitation in Alzheimer's dementia - recommendations of an expert, multispecialty advisory panel

Grossberg GT, Sanford A, Montano CB, Porsteinsson AP, Scanland S, Worz C, McMillian S, Atri A.

Postgrad Med. 2025 Aug;137(6):469-485. doi: 10.1080/00325481.2025.2517535. Epub 2025 Jun 17.

Stem cell-based therapeutic strategies for down syndrome and Alzheimer's disease

Hamadelseed O, Skutella T.

Stem Cell Res Ther. 2025 Aug 5;16(1):420. doi: 10.1186/s13287-025-04556-3.

Pharmacoutilization data-driven artificial intelligence-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia

Scuteri D, Adornetto C, Greco G, Nicotera P, Bagetta G, Corasaniti MT.

Curr Opin Pharmacol. 2025 Oct;84:102563. doi: 10.1016/j.coph.2025.102563. Epub 2025 Jul 28.

Case Report: Care of the Agitated Emergency Department Patient With Alzheimer's Disease

McGillivray IL, Chen A, Normandin PA.

J Emerg Nurs. 2025 Jul;51(4):553-569. doi: 10.1016/j.jen.2025.04.002.

Auditory Hallucinations as the First Symptom of Alzheimer´s Disease - A Case Report

Husing T, Quante A.

Curr Alzheimer Res. 2025;22(11):864-867. doi: 10.2174/0115672050421769250929051818.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias